Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Historical H. pylori regimens, the pediatric weight table and lifelong MAC statement are preserved from the source; they are not independently verified current treatment recommendations. IR and XL are distinct formulations.
The handbook renal dose ranges and selected U.S. label dose-reduction rules differ. Current label instructions and patient-specific interactions must be reviewed; the sources are not counted as agreeing.
Check source scope before reading a dose
Renal Drug Handbook, fifth edition
Product / population
Historical 2019 reference; renal bands retain the book's own method labels.
Renal method
Not specified
Source revision
Not established
Retrieved
2026-09-05
Local review status
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Handbook
Renal Drug Handbook, fifth edition
UK Renal Pharmacy Group / Ashley and Dunleavy / CRC Press · Historical 2019 reference; renal bands retain the book's own method labels.
Renal method: Not specified in this summary. Source date: Not established Retrieved: 2026-09-05
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Historical renal and dialysis statements
The handbook lists normal dosing at GFR 30-50 and oral 250-500 mg every 12 hours in both 10-30 and <10 bands. Its HD/APD/CAPD rows say not dialysed and refer to the <10 band; high-flux and continuous clearance are unknown. It warns about high-dose vomiting below 10 and the potentially fatal colchicine interaction.
The book's dose ranges do not consistently implement the current selected U.S. label's 50% reduction. The IV and XL regimens in the book are not transferred into this immediate-release U.S. tablet summary. No Stanford validation is asserted.
Source identity and provenance
Retrieved
2026-09-05
Handbook page
Printed page 223-224; PDF page 242-243
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.